News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
Rami Manochakian: Takeda Oncology announced voluntary WITHDRAWAL of Mobocertinib (in the US and globally) for patients with advanced EGFR, Exon20 insertion mutation-positive non-small cell lung cancer, after negative exclaim2 trial.
Photo taken from Rami Manochakian/Twitter
Oct 4, 2023, 17:57

Rami Manochakian: Takeda Oncology announced voluntary WITHDRAWAL of Mobocertinib (in the US and globally) for patients with advanced EGFR, Exon20 insertion mutation-positive non-small cell lung cancer, after negative exclaim2 trial.

Rami Manochakian, Associate Professor and Hematology/Oncology Fellowship Director at Mayo Clinic, shared on X/Twitter:

“Hot off the press.

Takeda Oncology announced voluntary WITHDRAWAL of Mobocertinib (in the US and globally) for patients with advanced EGFR, Exon20 insertion mutation-positive non-small cell lung cancer, after negative Exclaim2 trial.”

 

Rami Manochakian: Takeda Oncology announced voluntary WITHDRAWAL of Mobocertinib (in the US and globally) for patients with advanced EGFR, Exon20 insertion mutation-positive non-small cell lung cancer, after negative exclaim2 trial.

For deteils click here.
Source: Rami Manochakian/Twitter

cancer Lung cancer Mayo Clinic Mobocertinib OncoDaily Oncology Rami Manochakian
Special Coverage
Blog
Nov 21, 2024, 10:02
Staying current on cutting edge research into genetic/familial high-risk assessment - NCCN
Blog
Nov 21, 2024, 09:55
New Hope for Mantle Cell Lymphoma Patients - The Babak Lab
Blog
Nov 21, 2024, 09:28
Championing Children’s Health event at the European Parliament! - SIOP Europe
Blog
Nov 21, 2024, 09:23
Sachin H. Jain: Timeless lessons my father taught me about healthcare
Positive
Nov 21, 2024, 09:18
Vivek Subbiah: Delighted to welcome Krish Patel as our new lymphoma leader SCRI
Blog
Nov 21, 2024, 09:04
Tracey O'Brien: Lung cancer doesn’t discriminate
Blog
Nov 21, 2024, 06:52
Sylvester’s third annual Art is Medicine exhibit's new theme is "The Bridge to Bahia"
Blog
Nov 21, 2024, 06:49
OncoInfluencers to Follow on Social Media: Dr. Melvin L.K. Chua
Blog
Nov 21, 2024, 06:44
Hedley Lewis: Gratitude to all The Cows who participated in the Virgin Active South Africa Ride Joburg
Insight
Nov 21, 2024, 06:29
Sami Mansfield: What if improving metabolic health could reduce cancer risks and improve outcomes?
Blog
Nov 21, 2024, 06:27
Julie Gralow: Comprehensive Genomic Profiling Improves Precision Therapy Use And Patient Survival
Insight
Nov 20, 2024, 20:44
Baris Turkbey: Excited to announce NCI Molecular Imaging members presenting their research at RSNA2024